Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.
about
Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing ControversiesHistological outcomes after focal high-intensity focused ultrasound and cryotherapyUrologic cancer in ChinaProspective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerDose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives.Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy.Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial)Reduced order constrained optimization (ROCO): clinical application to lung IMRT.Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.High-risk prostate cancer-classification and therapy.The management of high-risk, locally advanced, prostate cancer radiation therapyRisk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer.The importance of local control in high-risk locally advanced prostate cancer.Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mixAnatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.Salvage HIFU for recurrent prostate cancer after radiotherapy.Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer.Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer.Postprostatectomy radiation therapy: an evidence-based review.Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.Imaging treated prostate cancer.Canadian prostate brachytherapy in 2012.Next-generation therapy for residual prostate cancer.FROGG high-risk prostate cancer workshop: patterns of practice and literature review: part I: intact prostate.Synergistic action of image-guided radiotherapy and androgen deprivation therapy.Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.Beam distortion due to gold fiducial markers during salvage high-intensity focused ultrasound in the prostate.Androgen receptor signaling regulates DNA repair in prostate cancers.Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancerPMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer.Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes.Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer.Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer.Curative radiation therapy in prostate cancer.A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy.Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer.
P2860
Q26744606-854D8BDD-A1BF-4B53-BA6C-749F6D82AD5FQ26820469-78353E42-712D-4E15-9FDD-AA076E45364AQ28075748-E74A0E6A-1112-4CD6-97F9-3D71C3AFF02FQ33415382-C0CA0920-73E8-436E-8E16-9012B1CCB1AFQ33679365-436EC6F1-7E5D-4F9C-8183-997BC4B48913Q34024161-D3AE146E-55C8-4202-A8D6-91CEDC065834Q34355171-6EFFC26A-72DE-4B76-A111-F3F22CC20271Q34629967-0CB96530-9FC8-4FD9-9BB1-767B73B0F79CQ34855696-A9F8D391-151E-447A-89ED-B1BC19025A1CQ35023746-B7792987-6798-4257-9FC0-46B956FEFCE1Q35781022-6FF1152F-576D-4107-9633-C06CE39D28B5Q35869811-5C0CE040-EC98-4F6B-AA57-AA66F5C1ADA8Q36338835-DDDB98FD-5DD8-4191-A685-87F181292E0DQ36355814-916C49CC-543C-4B21-A3A2-0585062EFCE5Q36557988-04DECF2D-368A-4132-B2AE-757CA7EA00B4Q36634718-9021A1DE-C03C-4232-88FA-7643F1D7E114Q37065578-7A5A2A51-3556-42D8-8EEE-C165F5D6F5A8Q37214143-03373785-9A2A-4508-BC15-C1EE2F36EE0FQ37293116-CC29604B-7243-4A4D-B3C8-964129755FFCQ37308234-E7B3D468-1C18-417C-869D-BD346BAA431CQ37702493-D4197B91-AACF-46E4-B66B-FCA0A340EC1AQ37960204-CE4FD97D-0151-4B9E-9E5E-5DB3993A28D2Q37965553-C746ED4D-98A5-4605-A0D8-93F3E44AE49EQ38100661-2058EF72-A8A7-4D08-839B-04AAD89D421FQ38106699-BC1FBECD-2ACA-4B08-9090-445CB6B38ED6Q38159804-B002C4F3-F53C-4B4F-93D9-AA14B042DA86Q38168635-944505A2-3117-4ACF-B586-2D62FFDE9A33Q38387844-F30F78B3-FC0C-45E7-A6B3-335116A2D21BQ38990477-54C435BB-C328-430C-9606-BAF0155D007BQ39061948-D65DB340-7B51-4FA4-B663-B492C580171DQ39096880-F41B4D71-CAA8-446A-A3DF-D7B5110E1A7CQ39724232-F7BE3AAB-D4AE-4C68-8643-492D1368C45EQ40738452-910954C0-ED64-480B-9034-20C38F721608Q41073444-AED71017-F967-4D07-8343-5850F8717C5CQ41284078-795CE3A8-ADFF-478E-BD6A-25A6968B5747Q43669783-55E1005F-7D48-441C-B041-0DC7793F64B4Q44124651-F9BD596B-E2B8-477A-860E-CF10383B2CF8Q44666799-888DD2D1-56FE-4A17-BDB0-E577E267275AQ45985789-CE3517BF-2BA5-4C77-BC5A-5C1B306FEFBFQ46061303-DF56C5EA-0605-4371-963B-18BC5BB09FF2
P2860
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of local tumor contr ...... iotherapy for prostate cancer.
@en
Influence of local tumor contr ...... iotherapy for prostate cancer.
@nl
type
label
Influence of local tumor contr ...... iotherapy for prostate cancer.
@en
Influence of local tumor contr ...... iotherapy for prostate cancer.
@nl
prefLabel
Influence of local tumor contr ...... iotherapy for prostate cancer.
@en
Influence of local tumor contr ...... iotherapy for prostate cancer.
@nl
P2093
P2860
P1476
Influence of local tumor contr ...... iotherapy for prostate cancer.
@en
P2093
Alison Shippy
Peter Scardino
Victor E Reuter
P2860
P304
1368-73; discussion 1373
P356
10.1016/J.JURO.2007.11.063
P407
P577
2008-03-04T00:00:00Z